Affiliation:
1. Eye Clinic, Sant'Anna University Hospital, Ferrara, Italy
Abstract
:
This review focuses on 5 new anti-VEGF drugs in the advanced stage of clinical development
(i.e., phase 3): conbercept, brolucizumab, port delivery system with ranibizumab, abicipar pegol
and faricimab.
:
Results of clinical trials and the advantages of each drug compared to the available molecules are discussed
in detail.
Publisher
Bentham Science Publishers Ltd.
Subject
Clinical Biochemistry,Drug Discovery,Pharmacology,Molecular Medicine
Cited by
14 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献